Company Albert Labs International Corp. OTC Markets
Equities
ALBLF
CA0127841041
Biotechnology & Medical Research
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
- USD | -.--% |
|
-.--% | -.--% |
Business Summary
Managers
Managers | Title | Age | Since |
---|---|---|---|
Michael Raymont
CEO | Chief Executive Officer | 74 | - |
Robert Kang
DFI | Director of Finance/CFO | - | - |
Chief Tech/Sci/R&D Officer | 61 | - | |
Navchand Jagpal
COO | Chief Operating Officer | - | - |
Graeme McFarlane
PRN | Corporate Officer/Principal | - | - |
Corporate Officer/Principal | - | - |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Michael Raymont
CEO | Chief Executive Officer | 74 | - |
Navchand Jagpal
COO | Chief Operating Officer | - | - |
Ravinder Kang
BRD | Director/Board Member | 58 | - |
Mike Thompson
BRD | Director/Board Member | - | 22-07-10 |
Richard Skaife
BRD | Director/Board Member | - | - |
Frank J. Lane
BRD | Director/Board Member | 57 | - |
Robert Kang
DFI | Director of Finance/CFO | - | - |
Director/Board Member | - | 22-07-10 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 74,413,267 | 63,035,215 ( 84.71 %) | 0 | 84.71 % |
Company contact information
Albert Labs International Corp.
6996, Merritt Avenue
V5J 4R6, Burnaby
+778-819-0740
http://www.albertlabs.com![address Albert Labs International Corp.(ALBLF)](https://cdn.zonebourse.com/static/address/166577859.png)
Sector
Sales per region
1st Jan change | Capi. | |
---|---|---|
+19.41% | 45.51B | |
-8.62% | 38.52B | |
+39.02% | 38.13B | |
+26.95% | 30.74B | |
-13.50% | 26.03B | |
+10.74% | 25.92B | |
+44.87% | 14.13B | |
+34.36% | 12.73B | |
-7.14% | 11.29B |
- Stock Market
- Equities
- ABRT Stock
- ALBLF Stock
- Company Albert Labs International Corp.